Neogen (NEOG) Net Income Growth (1y) (2011 - 2026)
Neogen (NEOG) Net Income Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 18.55% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 99.11% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 89.28% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -30.10% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 125.69% |
| 10 | Neogen | 2.03 Bn | 1.87 Bn | 99.00 Mn | -55.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -55.96% |
| Nov 30, 2025 | 96.51% |
| Aug 31, 2025 | 388.19% |
| May 31, 2025 | -11,930.27% |
| Feb 28, 2025 | -439.07% |
| Nov 30, 2024 | -12,985.23% |
| Aug 31, 2024 | -938.92% |
| May 31, 2024 | -184.85% |
| Feb 29, 2024 | -124.69% |
| Nov 30, 2023 | 91.67% |
| Aug 31, 2023 | -71.15% |
| May 31, 2023 | -55.11% |
| Feb 28, 2023 | 50.47% |
| Nov 30, 2022 | -486.41% |
| Aug 31, 2022 | -69.50% |
| May 31, 2022 | -0.86% |
| Feb 28, 2022 | -59.31% |
| Nov 30, 2021 | -31.84% |
| Aug 31, 2021 | 7.67% |
| May 31, 2021 | -12.28% |